- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
834
Companies which are more than 50% undervalued based on analyst price target.
834 companies
Rakovina Therapeutics
Market Cap: CA$6.3m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.045
7D
-10.0%
1Y
-47.1%
Sunshine Biopharma
Market Cap: US$4.5m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.25
7D
-8.8%
1Y
-93.0%
Azitra
Market Cap: US$4.5m
An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.
AZTR
US$0.29
7D
-4.8%
1Y
-95.4%
Dermata Therapeutics
Market Cap: US$4.4m
A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.
DRMA
US$0.81
7D
-6.8%
1Y
-84.9%
SenesTech
Market Cap: US$4.4m
Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
SNES
US$2.71
7D
12.9%
1Y
-60.1%
PHAXIAM Therapeutics
Market Cap: €3.8m
A biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States.
PHXM
€0.38
7D
22.6%
1Y
-87.2%
Sprint Bioscience
Market Cap: SEK 40.5m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.58
7D
-6.5%
1Y
-58.6%
Adial Pharmaceuticals
Market Cap: US$4.1m
A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
ADIL
US$0.60
7D
-10.3%
1Y
-59.9%
Sonnet BioTherapeutics Holdings
Market Cap: US$4.0m
A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.
SONN
US$1.28
7D
-5.9%
1Y
-90.6%
CERo Therapeutics Holdings
Market Cap: US$3.9m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$0.65
7D
-23.7%
1Y
-99.5%
Oragenics
Market Cap: US$3.9m
A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.
OGEN
US$0.17
7D
-13.5%
1Y
-90.8%
Galecto
Market Cap: US$3.8m
A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
GLTO
US$2.75
7D
-8.2%
1Y
-83.8%
Quoin Pharmaceuticals
Market Cap: US$3.7m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$6.19
7D
1.5%
1Y
-77.1%
Kazia Therapeutics
Market Cap: US$3.6m
Operates as an oncology-focused biotechnology company in South Korea.
KZIA
US$3.62
7D
-5.2%
1Y
-74.7%
Biodexa Pharmaceuticals
Market Cap: US$3.6m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$1.41
7D
0.7%
1Y
-93.9%
Alzamend Neuro
Market Cap: US$3.6m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$0.66
7D
-1.8%
1Y
-87.9%
VivoSim Labs
Market Cap: US$3.4m
A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.
VIVS
US$1.90
7D
-5.0%
1Y
-82.9%
Palisade Bio
Market Cap: US$3.4m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.75
7D
-4.8%
1Y
-88.8%
60 Degrees Pharmaceuticals
Market Cap: US$3.3m
A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
SXTP
US$2.39
7D
4.8%
1Y
-82.3%
NovaBay Pharmaceuticals
Market Cap: US$3.3m
Does not have significant operations.
NBY
US$0.56
7D
-3.9%
1Y
-80.0%
CNS Pharmaceuticals
Market Cap: US$3.3m
A clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.
CNSP
US$1.14
7D
0.9%
1Y
-99.8%
Artelo Biosciences
Market Cap: US$3.3m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$1.02
7D
0%
1Y
-23.9%
Tharimmune
Market Cap: US$3.1m
A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.
THAR
US$1.51
7D
-1.3%
1Y
-73.2%
Eyenovia
Market Cap: US$3.1m
A commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therapeutics.
EYEN
US$1.08
7D
-7.7%
1Y
-98.2%
Enveric Biosciences
Market Cap: US$3.1m
A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
ENVB
US$1.28
7D
-0.8%
1Y
-90.4%
Spruce Biosciences
Market Cap: US$3.1m
A biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders.
SPRB
US$0.075
7D
1.0%
1Y
-91.0%
Windtree Therapeutics
Market Cap: US$3.0m
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$0.85
7D
-14.4%
1Y
-99.6%
Ensysce Biosciences
Market Cap: US$2.9m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.17
7D
-15.6%
1Y
-72.4%
Revelation Biosciences
Market Cap: US$2.8m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$3.18
7D
11.1%
1Y
-90.4%
Bone Biologics
Market Cap: US$2.3m
A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
BBLG
US$0.75
7D
3.8%
1Y
-61.0%
Cambium Bio
Market Cap: AU$3.5m
A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.
CMB
AU$0.19
7D
-13.6%
1Y
-72.9%
Medigene
Market Cap: €2.0m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.13
7D
0%
1Y
-95.4%
Medicine Man Technologies
Market Cap: US$1.7m
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.
SHWZ
US$0.02
7D
0%
1Y
-96.8%
Processa Pharmaceuticals
Market Cap: US$1.4m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.24
7D
3.2%
1Y
-88.6%
Lipigon Pharmaceuticals
Market Cap: SEK 13.9m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.094
7D
-9.1%
1Y
-66.5%
LungLife AI
Market Cap: UK£1.1m
A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.
LLAI
UK£0.035
7D
0%
1Y
-86.5%